Skip to main content
Veterinary Medicines

Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs

Authorised
  • CALCIUM GLUCONATE FOR INJECTION
  • Magnesium chloride hexahydrate
  • Sodium glycerophosphate pentahydrate

Auðkenning lyfsins

Heiti lyfs:
Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs
Kaltetan forte, 458,4 mg/ml + 125 mg/ml + 20 mg/ml, infuzinis tirpalas arkliams, galvijams ir kiaulėms
Virkt efni:
Dýrategundir:
  • Hestur
  • Nautgripir
  • Svín
Íkomuleið:
  • Til notkunar í bláæð

Upplýsingar um lyfið

Virkt efni / Styrkur:
  • Aðeins í boði í English
    458.40
    milligram(s)
    /
    1.00
    millilitre(s)
  • Aðeins í boði í English
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Aðeins í boði í English
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Lyfjaform:
  • Innrennslislyf, lausn
Withdrawal period by route of administration:
  • Intravenous use
    • Hestur
      • Mjólk
        5
        week
    • Nautgripir
      • Kjöt og innmatur
        5
        week
    • Svín
      • Kjöt og innmatur
        5
        week
ATC flokkun (dýralyf):
  • QA12AX
Staða markaðsleyfis:
  • Gilt
Authorised in:
  • Litáen
Available in:
  • Litáen
Áletrun:

Viðbótarupplýsingar

Entitlement type:
  • Markaðsleyfi
Markaðsleyfishafi:
  • Vet-Agro Multi-Trade Company Sp. z o.o.
Marketing authorisation date:
Framleiðandi sem ber ábyrgð á lokasamþykkt:
  • Multi-Trade Company "Vet-Agro" Sp. z o.o.
Ábyrgt yfirvald:
  • State Food And Veterinary Service
Markaðsleyfisnúmer:
  • LT/2/22/2697/001
Dagsetning leyfisbreytingar:
Umsjónarland (RMS):
  • Pólland
Númer verkferlis:
  • PL/V/0110/002
Þátttökulönd (CMS):
  • Búlgaría
  • Tékkland
  • Grikkland
  • Ungverjaland
  • Ítalía
  • Litáen
  • Portúgal
  • Rúmenía
  • Spánn

Skjöl

RV2697.pdf

Lithuanian (PDF)
Birt á: 25/07/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."